Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy.
Ando M, Nishimura T, Yamazaki S, Yamaguchi T, Kawana-Tachikawa A, Hayama T, Nakauchi Y, Ando J, Ota Y, Takahashi S, Nishimura K, Ohtaka M, Nakanishi M, Miles JJ, Burrows SR, Brenner MK, Nakauchi H. Ando M, et al. Among authors: ando j. Stem Cell Reports. 2015 Oct 13;5(4):597-608. doi: 10.1016/j.stemcr.2015.07.011. Epub 2015 Aug 28. Stem Cell Reports. 2015. PMID: 26321144 Free PMC article.
Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo.
Ando M, Ando J, Yamazaki S, Ishii M, Sakiyama Y, Harada S, Honda T, Yamaguchi T, Nojima M, Ohshima K, Nakauchi H, Komatsu N. Ando M, et al. Among authors: ando j. Haematologica. 2020 Mar;105(3):796-807. doi: 10.3324/haematol.2019.223511. Epub 2019 Jul 11. Haematologica. 2020. PMID: 31296577 Free PMC article.
Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma.
Harada S, Ando M, Ando J, Ishii M, Yamaguchi T, Yamazaki S, Toyota T, Ohara K, Ohtaka M, Nakanishi M, Shin C, Ota Y, Nakashima K, Ohshima K, Imai C, Nakazawa Y, Nakauchi H, Komatsu N. Harada S, et al. Among authors: ando j, ando m. Mol Ther. 2022 Feb 2;30(2):534-549. doi: 10.1016/j.ymthe.2021.10.006. Epub 2021 Oct 8. Mol Ther. 2022. PMID: 34628050 Free PMC article.
iPSC-Derived Neoantigen-Specific CTL Therapy for Ewing Sarcoma.
Ishii M, Ando J, Yamazaki S, Toyota T, Ohara K, Furukawa Y, Suehara Y, Nakanishi M, Nakashima K, Ohshima K, Nakauchi H, Ando M. Ishii M, et al. Among authors: ando j, ando m. Cancer Immunol Res. 2021 Oct;9(10):1175-1186. doi: 10.1158/2326-6066.CIR-21-0193. Epub 2021 Aug 12. Cancer Immunol Res. 2021. PMID: 34385178
Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases.
Yasuda H, Ando J, Yoshida S, Ota Y, Komatsu N, Ando M. Yasuda H, et al. Among authors: ando j, ando m. Intern Med. 2023 Feb 15;62(4):601-604. doi: 10.2169/internalmedicine.0130-22. Epub 2022 Jul 5. Intern Med. 2023. PMID: 35793959 Free PMC article.
Primary Lymphoma of the Pericardium.
Kinoshita S, Ando J, Ando M, Komatsu N. Kinoshita S, et al. Among authors: ando j, ando m. Intern Med. 2021 Dec 15;60(24):4005-4006. doi: 10.2169/internalmedicine.7643-21. Epub 2021 Jun 12. Intern Med. 2021. PMID: 34121016 Free PMC article. No abstract available.
518 results